Similar results have been described in amyotrophic lateral sclerosis (ALS) mouse models, where the genetic ablation of IP3R2 showed no impact on disease onset and motor coordination although worsened muscular strength and decreased survival of the SOD1G23A mice [57]. This evidence concerns the gene ITPR2 and amyotrophic lateral sclerosis.